CIK 0001818844
- Non-accelerated filer
- Smaller reporting company
Dogwood Therapeutics, Inc.
Sign in to watch- Ticker
- DWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 854314201
- Phone
- +1 866-620-8655
- Business address
- 44 MILTON AVENUE, ALPHARETTA, GA, 30009
- Former names
- Virios Therapeutics, Inc., Virios Therapeutics, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-05 | Walsh Angela Chief Financial Officer | Grant or award · Stock Option (right to buy) | +82,500 | 82,500 | ||
| 2025-12-04 | Walsh Angela Chief Financial Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2025-06-27 | Walsh Angela Chief Financial Officer | Grant or award · Stock Option (right to buy) | +12,075 | 12,075 | ||
| 2024-02-26 | Walsh Angela SVP OF FINANCE | Grant or award · Stock Option (right to buy) | +63,618 | 63,618 | ||
| 2022-12-12 | Walsh Angela SVP OF FINANCE | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2022-06-23 | Walsh Angela SVP OF FINANCE | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-05-23 | Walsh Angela SVP OF FINANCE | Purchase | +2,000 | $4.58 | $9K | 3,000 |
| 2021-06-21 | Walsh Angela SVP OF FINANCE | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2021-01-28 | Walsh Angela VP of Finance | Purchase | +1,000 | $7.30 | $7K | 1,000 |
| 2021-01-11 | Walsh Angela VP of Finance | Grant or award · Stock Option (right to buy) | +209 | 41,621 | ||
| 2020-12-21 | Walsh Angela VP of Finance | Grant or award · Stock Option (right to buy) | +41,412 | 41,412 |
Page 1 of 1 · 11 trades